Curaleaf Laboratories recalls Curaleaf Oil due to low THC content
Curaleaf Laboratories is recalling three batches of Curaleaf Oil due to low THC content.
Asset / Drug
Drug and asset intelligence for Curaleaf with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.